TILs play a pivotal role in the efficacy of immunotherapeutic treatments such as checkpoint inhibitors. These therapies aim to enhance the immune system's ability to recognize and destroy cancer cells. The presence of TILs within a tumor can indicate an existing immune response, which may be further amplified by immunotherapy, leading to improved patient outcomes.
